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Abstract
Background: The contribution of HIV-exposure to childhood mortality in a setting with widespread antiretroviral
treatment (ART) availability has not been determined.
Methods: From January 2012 to March 2013, mothers were enrolled within 48 h of delivery at 5 government
postpartum wards in Botswana. Participants were followed by phone 1–3 monthly for 24 months. Risk factors for
24-month survival were assessed by Cox proportional hazards modeling.
Results: Three thousand mothers (1499 HIV-infected) and their 3033 children (1515 HIV-exposed) were enrolled.
During pregnancy 58 % received three-drug ART, 23 % received zidovudine alone, 11 % received no antiretrovirals
(8 % unknown); 2.1 % of children were HIV-infected by 24 months. Vital status at 24 months was known for 3018
(99.5 %) children; 106 (3.5 %) died including 12 (38 %) HIV-infected, 70 (4.7 %) HIV-exposed uninfected, and 24 (1.
6 %) HIV-unexposed. Risk factors for mortality were child HIV-infection (aHR 22.6, 95 % CI 10.7, 47.5 %), child HIV-
exposure (aHR 2.7, 95 % CI 1.7, 4.5) and maternal death (aHR 8.9, 95 % CI 2.1, 37.1). Replacement feeding predicted
mortality when modeled separately from HIV-exposure (aHR 2.3, 95 % CI 1.5, 3.6), but colinearity with HIV-exposure
status precluded investigation of its independent effect. Applied at the population level (26 % maternal HIV
prevalence), an estimated 52 % of child mortality occurs among HIV-exposed or HIV-infected children.
Conclusions: In a programmatic setting with high maternal HIV prevalence and widespread maternal and child
ART availability, HIV-exposed and HIV-infected children still account for most deaths at 24 months. Lack of
breastfeeding was a likely contributor to excess mortality among HIV-exposed children.
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Background
The HIV pandemic has profoundly decreased child sur-
vival in sub-Saharan Africa [1–4]. Improvements in
strategies to prevent mother-to-child HIV infection
(PMTCT) partially reversed this trend, but a shift to for-
mula feeding as part of PMTCT efforts may have eroded
mortality gains related to pediatric HIV reduction [5, 6].
Additionally, HIV exposed but uninfected (HEU)
children have a known increased risk of death compared
with HIV-unexposed (HU) children [7–13], whether for-
mula fed or breastfed [14–19].
Botswana, an African country where under-five mortality
almost doubled from 1990 to 2000 due to HIV [4], began to
provide free formula to all HIV-exposed infants from birth
in 1999 and started the rollout of antiretroviral therapy
(ART) for HIV-infected adults and children in 2001. Begin-
ning in 2012, all pregnant women had access to 3-drug ART
for PMTCT. These PMTCT and ART program changes
have occurred without documentation of accurate child mor-
tality rates and the relative contributions of HIV-infected
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and HEU children to overall 24-month child mortality re-
main unknown.
Current methods to estimate childhood mortality typ-
ically underestimate deaths in areas with high HIV
prevalence [20], and clinical trials may similarly under-
estimate the true population rate because of increased
care and resources within a trial. At the request of the
Botswana Ministry of Health and with the support of the
United States Centers for Disease Control and Preven-
tion (CDC), we performed a prospective observational
study to obtain accurate child mortality rates, account-
ing for HIV status and infant feeding practices, to better
understand overall risk and identify modifiable risk fac-
tors for child mortality in Botswana. Our study followed
a cohort of mothers and infants for 24 months post-
partum using telephone follow up in order to have min-
imal impact on clinical outcomes.
Methods
An equal number of HIV-infected and HIV-uninfected
mothers and their infants were enrolled at five geographic-
ally diverse public hospital maternity wards throughout
Botswana: Deborah Retief Memorial Hospital (DRM) in
Mochudi, Nyangabwe Referral Hospital (NH) in Fran-
cistown, Letsholathebe Memorial Hospital (LMH) in
Maun, Bamalete Lutheran Hospital (BLH) in Ramotswa
and Seventh Day Adventist Hospital (SDA) in Kanye.
These hospitals were chosen to maximize geographic
diversity but maintain adequate number of deliveries to
reach recruitment goals and include one tertiary refer-
ral center (NRH), one district hospital, and three re-
gional hospitals. In Botswana, approximately 95 % of
women delivery at maternity wards [21].
We systematically approached all HIV-infected mothers
and the same number of HIV-uninfected mothers on the
post-partum ward for enrollment in our study at each site
during working hours (M-F 7:30-4:30). Mothers were ex-
cluded if they lived >100 km away, were unwilling to be
contacted by telephone, or could not provide a con-
tact number (mothers without their own phones were
encouraged to provide a number for a relative, friend,
neighbor or workplace).
We conducted follow up visits via telephone at one
and three months, then every three months until
24 months post-partum. Maternal demographics, med-
ical and obstetric history and HIV testing and treatment
history were collected at baseline. During follow up we
assessed vital status of both mother and child, informa-
tion about child feeding method and vaccinations, child
and maternal hospitalizations, food security, medica-
tions, time child and mother were apart and HIV testing.
Participants who could not be contacted by phone were
visited at home (if they had provided permission).
Mothers were followed until death, completion of study
or death of their infant. Infants were followed until
death or completion of the study, regardless of maternal
survival.
Study participants received routine care through
Botswana government providers, and HIV-infected
mothers and children were eligible to receive ART and
PMTCT according to Botswana national HIV guidelines
(free for Botswana citizens). During our study guidelines
changed: from February- May 2012, pregnant HIV-
infected women with CD4 ≤ 350 cells/mm3 or WHO
clinical stage three or four could start combination ART
(primarily ZDV/lamivudine[3TC]/Nevirapine[NVP]) to
be continued life-long and pregnant women with CD4
counts >350 cells/mm3 were eligible to start ZDV alone
during pregnancy. From June 2012, all pregnant women
were eligible to start ART with Atripla (tenofovir/emtri-
citabine/efavirenz) at government HIV clinics. Guide-
lines recommended mothers with CD4 ≤ 350 cells/mm3
continue ART life-long [22].
HIV-exposed infants were tested for HIV in the gov-
ernment system at six weeks by PCR and 18 months by
ELISA. As part of the study, dried blood spots (DBS)
were collected among all HIV-exposed infants at enroll-
ment and selectively tested by PCR at the end of the
study if no other HIV testing was available or if HIV in-
fection was reported. HIV-infected children were eligible
to receive ART at the time of diagnosis which generally
consisted of lopinavir/ritonavir/ZDV/3TC.
Feeding
In Botswana, HIV-uninfected mothers are counseled to
breastfeed exclusively. HIV-infected mothers are coun-
seled to exclusively formula feed and receive free for-
mula, though HIV treatment guidelines were updated in
June 2012 to allow mothers receiving ART to choose to
breastfeed. At each follow up encounter mothers were
asked about infant feeding practices (breastfeeding, for-
mula feeding, supplementary water and/or solid foods).
For analysis we categorized feeding as ever vs. never
breastfed. Among infants surviving at least 28 days, we
also compared breastfeeding for at least one month vs.
all others (breastfeeding less than one month or never
breastfeeding).
Child and maternal outcomes
Children were considered HIV-infected by any positive
HIV PCR test or a positive HIV ELISA after 17 months.
Exclusively formula fed children were considered HIV-
uninfected if they had a negative HIV-test after four
weeks, while breastfed children required a negative HIV
test at least four weeks after weaning. In the primary
analysis, HIV-exposed children with unknown infection
status were considered HIV-uninfected. Since early
mortality may have precluded determination of HIV-
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serostatus, additional sensitivity analyses were performed
that 1) assumed HIV-unknown children who died were
HIV-infected and 2) assumed HIV-unknown children
who were “high risk” were HIV-infected. “High-risk” was
defined as children whose mothers had < four weeks of
ARVs (including no ARVs) in pregnancy.
Child deaths, maternal deaths, and the date of death
were reported by the primary caregiver reached at
follow-up. Verbal autopsy was performed for children
who died using structured interviews. The cause of
death was categorized by consensus of physician mem-
bers of the study team (blinded to all information except
verbal autopsy).
Projections of 24-month child mortality in Botswana
were calculated by applying the cumulative mortality
rate for HIV-infected, HEU and HU infants found in this
study to hypothetical populations of children made by
varying maternal HIV prevalence from 5 to 30 % and
MTCT rates from 0 to 20 %.
Statistical analysis
Cumulative child mortality was calculated from partici-
pants with complete follow up and mortality rate is pre-
sented as deaths per 1000child- years. Risk factors for
mortality were assessed using Cox proportional hazards
modeling for all children and separately for HEUs.
Time-varying risk factors were feeding (BF vs. no BF),
receipt of medications, separation from caregiver, intro-
duction of solid food, food insecurity, and maternal vital
status. Multivariate models included non-collinear co-
variates with a p-value <0.20. Maternal age and CD4
count (in HEU model) were also included due to pre-
viously established association with child mortality
[12, 23]. Infants found to be HIV-infected at their
six-week PCR were assumed infected in utero or peri-
partum and therefore considered HIV-infected for the
entire study. However, because timing of seroconver-
sion was uncertain we also separately modeled early
mortality (<43 days) by HIV-exposure status alone
and late mortality (≥43 days) by both HIV-exposure
and HIV-infection status. All tests were two tailed
and p-values of <0.05 were considered statistically sig-
nificant. Statistical analyses were performed with SAS,
version 9.4 (SAS Institute, Cary, North Carolina).
Results
Between January 2012 and March 2013 we enrolled
3000 mothers (1499 HIV-infected and 1501 HIV-
uninfected) and their 3033 infants (1515 HIV-exposed
and 1518 HIV-unexposed). This represented 21 % of all
deliveries, and 37 % of all HIV-infected deliveries at par-
ticipating sites. Enrollment corresponded to size of the
delivery ward, with 46 % of participants enrolled in Fran-
cistown, 28 % in Maun, 11 % in Kanye, 9 % in Mochudi,
and 6 % in Ramotswa. HIV-infected mothers tended to
be older, multi-gravid and have lower educational attain-
ment than HIV-uninfected mothers (all p < 0.001)
(Table 1). HIV-infected mothers were also less likely to
have an indoor toilet and water piped directly into the
house (p < 0.001). Infants born to HIV-infected women
were more likely to be born preterm (<37 weeks gesta-
tional age) and low birthweight (<2500 g) (Table 1). All
infants were discharged alive from the hospital.
The vast majority of HIV-unexposed infants were
breastfed (N = 1513, 99.7 %), with 99 % (N = 1505) having
breastfed for at least one month and 75 % (N = 1130) for
more than six months. In contrast, only 16 % (N = 249) of
HIV-exposed infants were ever breastfed;13 % (N = 195)
for at least one month and 1.4 % (N = 21) for more than
six months. Less than one-third of HIV-infected infants
(N = 9, 28 %) were ever breastfed. The timing of the intro-
duction of solid food was similar between HIV-exposed
and HIV-unexposed infants; solid foods were reported in
74 % of HU infants and 71 % of HIV-exposed infants by
six months of age.
Infant HIV infection
Mother to child transmission of HIV at 24 months was
2.1 % and did not differ by site. One hundred twenty
children (8 %) had unknown HIV-status at 24-months;
44 (2.9 %) died before receiving an HIV test, 42 (2.8 %)
exclusively formula-fed children were never tested at or
after one month of age and 34 (2.2 %) children were
never tested after cessation of breastfeeding.
Hospitalizations
Overall, 414 (14 %) children were hospitalized at least once
during follow-up, including 170 (11 %) HU, 230 (16 %)
HEU, and 14 (44 %) HIV-infected children (p < 0.001).
HEU children were 1.6 times more likely than HU children
to spend >3 weeks in the hospital (RR 1.6, 95 % CI 0.8,3.4),
though this result was not statistically significant. Of the
14 HIV-infected children who were hospitalized at least
once during follow-up, 75 % were in hospital for one to
three weeks.
24-month child mortality
We obtained vital status on 3018 (99.5 %) children at
24 months. Nine children withdrew from the study
and six were lost to follow up. Overall, 106 children
died, yielding a cumulative mortality of 3.5 % (18
deaths per 1000 child-years). The cumulative prob-
ability of death was 38 % (N = 12) among HIV-
infected children (300 deaths per 1000 child-years),
4.7 % (N = 70) among HEUs (24 deaths per 1000
child-years), and 1.6 % (N = 24) among HUs (8 deaths
per 1000 child-years). There was no significant differ-
ence in mortality by site. Almost one-third (30 %) of
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deaths occurred in the first 42 days of life, including
28 (34 %) among HIV-exposed infants (regardless of
infection) and four (17 %) among HIV-unexposed
infants.
Cause of death is shown in Table 2 and did not differ
significantly by HIV-exposure status (p = 0.25). In the
4 weeks prior to death, 90 (85 %) children were seen by
a healthcare provider, including 82 (77 %) who sought
Table 1 Maternal and infant baseline characteristics
Maternal characteristics HIV-infected (N = 1499) HIV-uninfected (N = 1501)
Age (median) 29 24
Primigravid 244 (16 %) 675 (45 %)
Gravidity ≥4 545 (36 %) 199 (13 %)
Married 122 (8 %) 145 (10 %)
Education
Primary/None 197 (13 %) 77 (5 %)
Secondary 1176 (78 %) 1127 (75 %)
Tertiary 126 (8 %) 297 (20 %)
Drinking water source
Communal standpipe 301 (20 %) 170 (11 %)
Tap in yard 977 (65 %) 1007 (67 %)
Piped directly into the home 209 (14 %) 317 (21 %)
Other/Unknown 12 (1 %) 7 (0.5 %)
Toilet facilities
No latrine facilities 107 (7 %) 60 (4 %)
Shared latrine with other compounds 69 (5 %) 53 (4 %)
Private latrine for house/compound 1028 (69 %) 946 (63 %)
Indoor Toilet 289 (19 %) 434 (29 %)
Other/Unknown 6 (0.4 %) 8 (1 %)
Electricity in the home 799 (53 %) 987 (66 %)
VDRL positive during pregnancy 32 (2 %) 25 (2 %)
1st Hemoglobin during pregnancy (median) 10.8 g/dl 11.3 g/dl
Infant characteristics HIV-exposed (N = 1515) HIV-unexposed (N = 1518)
Gender
Male 747 (49 %) 775 (51 %)
Female 768 (51 %) 743 (49 %)
Delivery method
Vaginal 1334 (88 %) 1387 (91 %)
Elective Cesarean section 21 (1 %) 16 (1 %)
Emergency Cesarean section 160 (11 %) 115 (8 %)
Gestational age at Delivery
Very preterm (≤32 week) 44 (3 %) 12 (1 %)
Preterm (33–37 weeks) 233 (15 %) 180 (12 %)
Term (≥37 weeks) 1228 (81 %) 1316 (87 %)
Unknown 10 (1 %) 10 (1 %)
Birthweight
Very low birthweight (≤1500 g) 2 (0.1 %) 2 (0.1 %)
Low birthweight (1500–2500 g) 252 (17 %) 111 (7 %)
Normal birthweight (>2500 g) 1261 (83 %) 1405 (93 %)
Required NNU 50 (3 %) 33 (2 %)
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care from a clinic or hospital, 3 (3 %) who were evalu-
ated by a traditional healer and 8 (8 %) seen by both. Of
the 14 children with no contact with the health care sys-
tem prior to death, four (29 %) died from accident/
trauma.
Risk factors for child mortality are shown in Table 3.
Compared with HU children, the chance of surviving to
24-months was lower among HIV-infected (aHR 21.7,
95%CI 10.3, 46.0) and HEU children (aHR 2.7, 95 % CI
1.6,4.5) (Fig. 1). Sensitivity analyses considering all HIV-
exposed children who died with unknown HIV status as
infected, or considering them infected if they were high-
risk, did not significantly change the effect of HIV-
exposure on survival (data not shown). Other factors
significantly associated with 24-month mortality among
all children in adjusted analyses were maternal death
(aHR 8.9, 95%CI 2.1,37.1) and birth during the rainy sea-
son (January-March) (aHR 1.8, 95%CI 1.2, 2.6). Although
mortality risk among formula fed children was signifi-
cantly increased when modeled separately from HIV-
exposure status (aHR 2.3, 95 % CI 1.5, 3.5), feeding and
HIV-exposure status were collinear and could not be
modeled together.
In a separate model among only HEU children, inde-
pendent risk factors for mortality included congenital ab-
normality (aHR 5.5 95 % CI 1.3, 23.8) and no/primary
maternal education (aHR 2.7 95 % CI 1.2, 6.3) (Table 3).
The risk of death was non-significantly higher among HEU
children who were never breastfed compared with the rela-
tively small number (195) of HEU children who were
breastfed for at least a month (aHR 1.4, 95 % CI 0.5, 3.7).
Population impact of maternal HIV-infection on child
mortality
Applying the cumulative mortality (1.6 % for HU, 4.7 % for
HEU and 38 % for HIV-infected) and MTCT rate (2.1 %) to
the Botswana population, where 26 % of pregnant women
are HIV-infected (Shapiro, RL. Birth Outcomes in Botswana
study, unpublished data), over half of under-two mortality
is attributable to HIV-exposure (46 % of all deaths expected
to be HEUs and 8 % HIV-infected). Figure 2 demonstrates
the overall impact of both MTCT rate and maternal HIV
prevalence on childhood mortality based on the mortality
rates by exposure category determined in this study.
Discussion
We performed the largest study of 24-month child
mortality in Botswana since national scale-up of PMTCT
programs. Using cell phone follow up, we were able to
achieve a loss-to-follow-up (LTFU) rate of <0.5 % at
24 months. We confirmed previous findings that even if
uninfected, HIV-exposed children have decreased survival
compared with HIV-unexposed children and found very
high mortality among HIV-infected children, with little
improvement from the early ART era [5]. These two
groups combine to account for more than half of deaths
among children under two in Botswana. Mortality among
HIV-unexposed children in Botswana was low compared
with regional estimates [24], despite breastfeeding dura-
tions that fell short of WHO recommendations [25].
Higher mortality among HEU and HIV-infected chil-
dren may relate to lack of breastfeeding, but our analysis
could not untangle the impact of infant feeding method









Cause of Death (N, % of total deaths)
Diarrheal Illness 46 (43 %) 6 (50 %) 32 (46 %) 8 (33 %)
Pneumonia 14 (13 %) 1 (8 %) 9 (13 %) 4 (17 %)
Respiratory Illness 17 (16 %) 3 (25 %) 10 (14 %) 4 (17 %)
Other Infection 8 (8 %) 1 (8 %) 6 (9 %) 1 (4 %)
Trauma/Accident 5 (5 %) 0 2 (3 %) 3 (13 %)
Other (non-infectious) 5 (5 %) 0 3 (4 %) 2 (8 %)
Unable to classify 11 (10 %) 1 (8 %) 8 (11 %) 2 (8 %)
Death by season of Birth (N, % of total births who died)a
Jan-March (Rain, hot) (N = 995 total births) 50 (5 %) 6 (46 %) 31 (6 %) 13 (3 %)
Apr-June (Dry, temperate) (N = 1009 total births) 34 (3 %) 3 (30 %) 24 (5 %) 7 (1 %)
July–Sept (Dry, cool) (N = 631 total births) 11 (2 %) 3 (38 %) 6 (2 %) 2 (1 %)
Oct–Dec (Variable rain, hot) (N = 415 total births) 11 (3 %) 0 (0 %) 9 (5 %) 2 (1 %)
aThe % of deaths by season of birth was calculated as the number of deaths/total number of births in each time period. Among HIV-infected children there were
13 births in Jan–Mar, 10 in April–June, 8 in July–Sept and 1 in Oct–Dec. Among HIV-exposed uninfected children there were 505 births in Jan–Mar, 498 in April–
June, 287 in July–Sept and 193 in Oct–Dec. Among HIV-unexposed children there were 477 births in Jan–Mar, 501 in April–June, 319 in July–Sept and 221
in Oct–Dec
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Table 3 Risk factors for child mortality
All children (N = 3033) HIV-exposed uninfected children (N = 1483)








Non-tertiary delivery site 1.1 (0.7,1.5) – 1.2 (0.7, 1.9) –
Infant congenital abnormalities 2.5 (0.9,6.8) 1.9 (0.7, 5.4) 4.6 (1.7, 12.5) 5.5 (1.3, 23.8)
Infant birth injuries 1.3 (0.6,2.7) – 1.8 (0.7, 4.5) 2.7 (0.8, 9.0)
Infant preterm (<37 weeks) 1.4 (0.9,2.3) 1.1 (0.7, 1.8) 1.4 (0.8, 2.4) 1.4 (0.7, 2.9)
Never Breastfed 2.5 (1.7,3.8) –a 1.0 (0.5,1.9) 1.4 (0.5, 3.7)
Introduction of solid food < 6 months 0.7 (0.3,1.4) – 0.9 (0.3,2.4) –
Season of birth: Jan–Mar 1.9 (1.3,2.7) 1.8 (1.2, 2.6) 1.6 (1.0,2.5) 1.4 (0.8, 2.8)
Infant HIV-infectedb 30.0 (15.0,60.0) 21.7 (10.3, 46) – –
Infant HIV-exposedb 3.5 (2.2,5.5) 2.7 (1.6, 4.5) – –
Water not piped directly into home 2.4 (1.2,4.7) 1.8 (0.8, 2.6) 2.1 (0.9. 5.1) 1.6 (0.5, 5.5)
No refrigerator in the home 1.2 (0.8,1.7) – 1.0 (0.6, 1.6) –
No/primary maternal education 2.1 (1.1,4.4) 1.5 (0.8, 2.6) 1.8 (1.0, 3.2) 2.7 (1.2, 6.3)
No indoor toilet 1.9 (1.1, 3.2) 1.0 (0.5, 2.0) 1.6 (0.8, 3.3) 0.7 (0.3, 1.9)
Cooking method: Paraffin or woodburning stove 1.4 (1.0,2.1) 1.0 (0.9, 1.6) 1.0 (0.6, 1.6) –
Maternal Death 9.0 (2.2,36.7) 8.9 (2.1,37.1) –c –c
Maternal Age 1.0 (1.0,1.0) 1.0 (0.9,1..0) 1.0 (1.1) 1.0 (0.9,1.0)
Mother Primiparous 0.6 (0.1,1.0) 0.9 (0.5,1.5) 1.2 (1.7,2.2) 0.8 (0.3,2.1)
Mother Married 0.6 (0.3,1.4) – 0.5 (0.2,1.6) 0.6 (0.1, 2.5)
Maternal ZDV monotherapy in pregnancy (reference 3-drug ART) – – 1.3 (0.8,2.1) 1.1 (0.6, 2.1)
Maternal CD4 < 250 cells/mL – – 0.9 (0.4,2.1) –
aDue to collinearity between HIV-exposure status and feeding choice (breast vs. formula feeding), feeding was unable to be added to the multivariate model.
When modeled separately, without HIV-exposusre status, the aHR of never breastfeeding was 2.3 (95 % CI 1.5,3.5)
bReference group is HIV-unexposed infants (HU)
cAmong all HEU infants who died, there were no maternal deaths. Therefore, maternal deaths could not be included as a covariate in the HEU model
Fig. 1 Survival from birth to 24 months among HIV-infected, HIV-exposed uninfected and HIV-unexposed children. Legend: Using the logrank test,
there is a significant difference in survival comparing HEU with HUU (p < 0.0001) and comparing HIV-infected with HUU (p < 0.0001)
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from the impact of HIV-exposure on child survival given
extreme collinearity. Although the risk of death for the
small number of HIV-exposed breastfed children was
lower than those who formula fed, this comparison was
underpowered and not statistically significant. We found
HIV-infected mothers who breastfed more commonly
had markers of lower socioeconomic status compared
with HIV-infected mothers who did not breastfeed (data
not shown). We would therefore expect HIV-exposed
breastfed babies to have higher mortality and so our ef-
fect estimate may be biased toward the null. In sum, al-
though we suspect that lack of breastfeeding may have
contributed to the higher mortality seen among HEUs,
our data were not able to conclusively demonstrate this
association.
Mortality among HIV-infected children remains simi-
lar to that seen in 2003–2006, near the beginning of the
rollout of pediatric ART in Botswana [5]. Our findings
were somewhat lower than cumulative 24-month mor-
tality (54 %) reported from a pooled analysis of African
countries, most of which had higher overall childhood
mortality rates [13]. Previous studies in Botswana have
demonstrated very high mortality risk among HIV-
infected infants who formula feed from delivery [15],
and this was likely a contributor in our cohort as well.
Although we did not collect data on ART use among
HIV-infected children, we know that children were not
initiated prior to diagnosis at their 6-week PCR. Given
the emerging data to supporting long-term benefits of
early ART initiation [26, 27], our study provides support
for HIV testing at birth (in addition to standard six week
testing) particularly in areas where formula feeding is
common and an HIV diagnosis within days of birth may
allow for appropriate counseling to initiate or maintain
breastfeeding for these high-risk children.
Infectious diseases were the primary cause of death for
all exposure groups, with diarrheal diseases and respira-
tory diseases most common. Seasonality of birth also ap-
peared to play a role, with children born during the
rainy season experiencing higher likelihood of death.
The reasons for this association are unknown but could
be due to a more contaminated water supply from the
rains, food scarcity in the period before the harvest
(May/June), or decreased support in the home because
family members are often needed for ploughing in this
time period. In our study, 88 % of children who died
from a cause other than trauma or accident in Botswana
had contact with the healthcare system shortly before
their death. Therefore, interventions to improve in-
patient treatment, recognize at-risk children, and im-
prove diagnostics among those with diarrhea and
respiratory symptoms could also improve outcomes.
Our study has several strengths, including a large and
geographically diverse sample, 99.5 % follow-up at
24 months and a study design with minimal impact on
child outcomes. However, our study likely underesti-
mates early neonatal mortality. All infants enrolled in
this study were discharged from the hospital alive and
proportionately fewer were very preterm (<37 weeks
GA) and very low birthweight (<2500 g) than in the
Fig. 2 Projected overall childhood mortality in Botswana with varying maternal HIV-infection prevalence and MTCT rate
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general Botswana population [28, 29]. Although we did
not exclude sick infants, mothers of the most critically
ill neonates may have been less likely to participate in a
study. Extrapolating from other studies of infant out-
comes at our study sites [28, 29], we estimate that early
in-hospital mortality missed by our study was approxi-
mately 1 %; because our sample was otherwise representa-
tive, we believe that our mortality estimates may have
underestimated overall 24-month mortality in the general
population by this amount. Also, while we attempted to
control for differences between HIV-infected and HIV-
uninfected mothers, unmeasured sociodemographic fac-
tors may confound the association between mortality and
HIV-exposure status. Our study was also limited in that
we were unable to conclusively know the HIV-infection
status on most infants who died before their six-week
HIV PCR.
Conclusions
This study highlights the impact of HIV exposure on
child mortality in Botswana, even with highly successful
and widespread PMTCT and ART programs. Child mor-
tality among HIV-unexposed children is low for the re-
gion, but achieving this low child mortality for all
children in Botswana will require interventions to de-
crease maternal HIV prevalence and improve outcomes
among those who are affected by HIV. Our analysis was
unable to determine the direct impact of infant feeding
on mortality. However, it seems logical that breastfeed-
ing should be a component of the strategy to improve
child outcomes in this setting where most women are on
ART and the majority of child deaths are due to diarrhea
and pneumonia. Ongoing surveillance to confirm that
mortality benefits outweigh the risk from late MTCT
among HIV-infected breastfeeding women is warranted.
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